BARD1 Life Sciences Ltd (BD1) Company Profile

BARD1 Life Sciences Ltd Company Snapshot

BARD1 Life Sciences Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares BARD1 Life Sciences Ltd with three other miscellaneous service companies in Australasia: Vectus Biosystems Ltd (2019 sales of 220.00 Australian Dollars [US$134.97 ] ), Australian Primary Hemp Ltd (11,076.00 Australian Dollars [US$6,795.13 ] ), and PYC Therapeutics Ltd (250.00 Australian Dollars [US$153.38 ] ).

Sales Analysis.

BARD1 Life Sciences Ltd

Stock Data:

Recent Stock Performance:

Current Price (3/27/2020): .02
(Figures in Australian Dollars)

1 Week	-4.8%	13 Weeks	-31.0%

4 Weeks	-39.4%	52 Weeks	26.0%

BARD1 Life Sciences Ltd Key Data:

Ticker:	BD1	Country:	Australia

Exchanges:	FRA OTC	Major Industry:	Commercial Services & Supplies

		Sub Industry:	Commercial Physical Research

2019 Sales	8,731 (Year Ending Jan 2020).	Employees:	85

Currency:	Australian Dollars	Market Cap:	27,343,701

Fiscal Yr Ends:	June	Shares Outstanding:	1,367,185,026

Share Type:	Ordinary	Closely Held Shares:	509,852,758

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.